This HTML5 document contains 49 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n4http://localhost/temp/predkladatel/
n10http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n8http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n15http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n14http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n13http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216208%3A11120%2F04%3A00000974%21RIV09-MSM-11120___/
n7http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216208%3A11120%2F04%3A00000974%21RIV09-MSM-11120___
rdf:type
n8:Vysledek skos:Concept
dcterms:description
práce popisuje užití rekombinantního aktivačního faktoru VII v kardiochirurgii pro efektivní léčbu vážného nezzvaldatelného krvácení Experience gained with administration of Supranormal-therapeutic doses (90 mug/kg) of recombinant activated factor VII in 7 cardiac surgery patients is presented. The patients were given recombinant activated factor VII postoperatively for intractable bleeding, 5 of them after surgical revision. Administration of recombinant activated factor VII was associated with significant reduction in blood loss (P < 0.05) and shortening of INR and aPTT in laboratory tests. None of the patients needed reoperation. Administration of recombinant activated factor VII proved highly effective in management of massive hemorrhage in cardiac surgery Experience gained with administration of Supranormal-therapeutic doses (90 mug/kg) of recombinant activated factor VII in 7 cardiac surgery patients is presented. The patients were given recombinant activated factor VII postoperatively for intractable bleeding, 5 of them after surgical revision. Administration of recombinant activated factor VII was associated with significant reduction in blood loss (P < 0.05) and shortening of INR and aPTT in laboratory tests. None of the patients needed reoperation. Administration of recombinant activated factor VII proved highly effective in management of massive hemorrhage in cardiac surgery
dcterms:title
Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding Užití rekombinantního aktivačního faktoru VII v kardiochirurgii pro efektivní léčbu vážného nezzvaldatelného krvácení
skos:prefLabel
Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding Užití rekombinantního aktivačního faktoru VII v kardiochirurgii pro efektivní léčbu vážného nezzvaldatelného krvácení
skos:notation
RIV/00216208:11120/04:00000974!RIV09-MSM-11120___
n3:aktivita
n14:S
n3:aktivity
S
n3:cisloPeriodika
5
n3:dodaniDat
n7:2009
n3:domaciTvurceVysledku
n10:8359067 n10:3924084 n10:8637180 n10:7452810 n10:2755696
n3:druhVysledku
n17:J
n3:duvernostUdaju
n12:S
n3:entitaPredkladatele
n13:predkladatel
n3:idSjednocenehoVysledku
591687
n3:idVysledku
RIV/00216208:11120/04:00000974
n3:jazykVysledku
n15:eng
n3:klicovaSlova
cardiac surgery; bleeding; recombinant activated factor VII
n3:klicoveSlovo
n5:cardiac%20surgery n5:recombinant%20activated%20factor%20VII n5:bleeding
n3:kodStatuVydavatele
JP - Japonsko
n3:kontrolniKodProRIV
[1B3D309FC3E6]
n3:nazevZdroje
Japanese Heart Journal
n3:obor
n16:FA
n3:pocetDomacichTvurcuVysledku
5
n3:pocetTvurcuVysledku
6
n3:rokUplatneniVysledku
n7:2004
n3:svazekPeriodika
45
n3:tvurceVysledku
Jareš, Martin Straka, Zbyněk Hrabák, J. Votava, Jan Vaněk, Tomáš Brůček, Petr
n3:wos
000226083000014
s:issn
0021-4868
s:numberOfPages
6
n4:organizacniJednotka
11120